HCA Healthcare (HCA) Shares Outstanding (Weighted Average) (2010 - 2026)

HCA Healthcare (HCA) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $223.6 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) fell 9.46% year-over-year to $223.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $223.6 million (down 9.46% YoY) and the FY2025 annual result came in at $236.4 million, down 8.58% from the prior year.
• Shares Outstanding (Weighted Average) declined to $223.6 million in Q1 2026 per HCA's latest filing, from $236.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $302.4 million in Q1 2022 and bottomed at $223.6 million in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $264.4 million (2024), against an average of $265.0 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) declined 12.83%; it then retreated 3.84% in 2024.
• Tracing HCA's Shares Outstanding (Weighted Average) over 5 years: stood at $290.3 million in 2022, then fell by 6.18% to $272.4 million in 2023, then slipped by 5.07% to $258.6 million in 2024, then dropped by 8.58% to $236.4 million in 2025, then decreased by 5.42% to $223.6 million in 2026.
• Per Business Quant, the three latest HCA Shares Outstanding (Weighted Average) figures stand at $223.6 million (Q1 2026), $236.4 million (Q4 2025), and $239.6 million (Q3 2025).

Peer Comparison